Voglixta 0.3MG Tab

Composition

Voglibose 0.3 mg

Uses of Voglixta 0.3MG Tab

Management of type 2 diabetes mellitus to reduce post‑prandial (after-meal) blood glucose; used alone or with other antidiabetic medicines along with diet and exercise.

• •Reduces post-meal blood sugar spikes
• •Helps improve overall glycaemic control
• •Useful add-on therapy in type 2 diabetes
• •Works locally in the gut with minimal systemic absorption

How it works

Voglibose is an alpha‑glucosidase inhibitor that delays breakdown and absorption of carbohydrates in the intestine. This reduces the rise in blood glucose after meals and helps improve overall glycaemic control.

Directions for use

Oral tablet. Typically taken just before or with the first bite of each main meal, as prescribed by the doctor. Swallow with water; do not skip meals after taking a dose. Follow diabetic diet and exercise advice.

Side effects

Common side effects of Voglixta 0.3MG Tab may include:

• •Flatulence
• •abdominal pain
• •diarrhoea
• •bloating
• •nausea

Warnings & precautions

Use with caution in patients with intestinal disorders (e.g., inflammatory bowel disease, colonic ulceration, partial intestinal obstruction), severe liver disease, or renal impairment. Risk of hypoglycaemia increases when combined with insulin or sulfonylureas—treat low sugar with glucose (dextrose), not sucrose, as carbohydrate absorption is delayed. Not for type 1 diabetes or diabetic ketoacidosis. Monitor blood glucose and HbA1c regularly.